Figure 1.
Approved bisphosphonate indications in the oncology setting. Abbreviations: HCM, hypercalcemia of malignancy; IV, intravenous. (Note: In the United States, prostate cancer must have progressed despite hormone therapy.)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.